| CAS NO: | 947687-13-0 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 生物活性 | Ramucirumab is a humanVEGFR-2antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding ofVEGFRligands:VEGF-A,VEGF-C, andVEGF-D. Ramucirumab is also an angiogenesis inhibitor[1][2]. | |
| IC50& Target[1][2] |
| |
| 体外研究 (In Vitro) | Ramucirumab (10 μg/mL) impedes both VEGF- and tumor-driven cord formation[3]. | |
| Clinical Trial | ||
| 分子量 | 143609.63 | |
| 性状 | Liquid | |
| Formula | C6374H9864N1692O1996S46 | |
| CAS 号 | 947687-13-0 | |
| 中文名称 | 雷莫芦单抗 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
